<DOC>
	<DOC>NCT01604161</DOC>
	<brief_summary>This study is conducted in Japan. The aim of this study is to collect information about the efficacy and safety of Norditropin® (somatropin) in the long-term treatment of short stature with GHD (Growth Hormone Deficiency) where epiphysial discs are not closed and short stature with Turner Syndrome where epiphysial discs are not closed.</brief_summary>
	<brief_title>Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism, Pituitary</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<criteria>Growth hormone deficiency or short stature due to Turner Syndrome where the epiphyseal discs are not closed Diabetic Patients with malignant tumors Women who are either pregnant or likely to be pregnant Known or suspected allergy to study product(s) or related products</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>